§ 13F · FUND PROFILE
DAFNA Capital Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $405M (13F)Positions · 75Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$9M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 581K | $56M | 12.8% | −4% |
| 2 | XBI | SPDR S&P BIOTECH ETF | 319K | $41M | 9.3% | −5% |
| 3 | STXS | STEREOTAXIS INC | 13.68M | $25M | 5.7% | ±0% |
| 4 | DAWN | DAY ONE BIOPHARMACEUTICALS I | 978K | $21M | 4.8% | −2% |
| 5 | ATRC | ATRICURE INC | 597K | $17M | 3.9% | ±0% |
| 6 | IDYA | IDEAYA BIOSCIENCES INC | 477K | $16M | 3.6% | −6% |
| 7 | XENE | XENON PHARMACEUTICALS INC | 251K | $15M | 3.3% | −13% |
| 8 | CYTK | CYTOKINETICS INC | 217K | $14M | 3.3% | −41% |
| 9 | CMPS | COMPASS PATHWAYS PLC | 2.42M | $13M | 3.0% | +198% |
| 10 | NKTR | NEKTAR THERAPEUTICS | 165K | $12M | 2.7% | +120% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE DAFNA SIGNAL
AC read
DAFNA Capital Management LLC is a Other fund managing $405 million in assets. The fund runs a portfolio of 75 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed